202 related articles for article (PubMed ID: 10471341)
1. Topically applied betaxolol attenuates NMDA-induced toxicity to ganglion cells and the effects of ischaemia to the retina.
Osborne NN; DeSantis L; Bae JH; Ugarte M; Wood JP; Nash MS; Chidlow G
Exp Eye Res; 1999 Sep; 69(3):331-42. PubMed ID: 10471341
[TBL] [Abstract][Full Text] [Related]
2. Topical flunarizine reduces IOP and protects the retina against ischemia-excitotoxicity.
Osborne NN; Wood JP; Cupido A; Melena J; Chidlow G
Invest Ophthalmol Vis Sci; 2002 May; 43(5):1456-64. PubMed ID: 11980861
[TBL] [Abstract][Full Text] [Related]
3. Topically applied betaxolol attenuates ischaemia-induced effects to the rat retina and stimulates BDNF mRNA.
Wood JP; DeSantis L; Chao HM; Osborne NN
Exp Eye Res; 2001 Jan; 72(1):79-86. PubMed ID: 11133185
[TBL] [Abstract][Full Text] [Related]
4. Protection of rabbit retina from ischemic injury by flupirtine.
Osborne NN; Schwarz M; Pergande G
Invest Ophthalmol Vis Sci; 1996 Feb; 37(2):274-80. PubMed ID: 8603831
[TBL] [Abstract][Full Text] [Related]
5. In vivo and in vitro experiments show that betaxolol is a retinal neuroprotective agent.
Osborne NN; Cazevieille C; Carvalho AL; Larsen AK; DeSantis L
Brain Res; 1997 Mar; 751(1):113-23. PubMed ID: 9098574
[TBL] [Abstract][Full Text] [Related]
6. Betaxolol attenuates retinal ischemia/reperfusion damage in the rat.
Cheon EW; Park CH; Kang SS; Cho GJ; Yoo JM; Song JK; Choi WS
Neuroreport; 2003 Oct; 14(15):1913-7. PubMed ID: 14561919
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the neuroprotective effects of adrenoceptor drugs in retinal cell culture and intact retina.
Baptiste DC; Hartwick AT; Jollimore CA; Baldridge WH; Chauhan BC; Tremblay F; Kelly ME
Invest Ophthalmol Vis Sci; 2002 Aug; 43(8):2666-76. PubMed ID: 12147601
[TBL] [Abstract][Full Text] [Related]
8. Protective effects of betaxolol in eyes with kainic acid-induced neuronal death.
Cheon EW; Park CH; Kim YS; Cho CH; Chung YC; Kwon JG; Yoo JM; Choi WS; Cho GJ
Brain Res; 2006 Jan; 1069(1):75-85. PubMed ID: 16387283
[TBL] [Abstract][Full Text] [Related]
9. Neuroprotective effect and intraocular penetration of nipradilol, a beta-blocker with nitric oxide donative action.
Mizuno K; Koide T; Yoshimura M; Araie M
Invest Ophthalmol Vis Sci; 2001 Mar; 42(3):688-94. PubMed ID: 11222528
[TBL] [Abstract][Full Text] [Related]
10. Assessment of Thy-1 mRNA levels as an index of retinal ganglion cell damage.
Nash MS; Osborne NN
Invest Ophthalmol Vis Sci; 1999 May; 40(6):1293-8. PubMed ID: 10235569
[TBL] [Abstract][Full Text] [Related]
11. Influence of excitatory amino acids and ischemia on rat retinal choline acetyltransferase-containing cells.
Osborne NN; Larsen A; Barnett NL
Invest Ophthalmol Vis Sci; 1995 Jul; 36(8):1692-700. PubMed ID: 7601649
[TBL] [Abstract][Full Text] [Related]
12. The beta-adrenoceptor antagonists metipranolol and timolol are retinal neuroprotectants: comparison with betaxolol.
Wood JP; Schmidt KG; Melena J; Chidlow G; Allmeier H; Osborne NN
Exp Eye Res; 2003 Apr; 76(4):505-16. PubMed ID: 12634114
[TBL] [Abstract][Full Text] [Related]
13. Topically applied clonidine protects the rat retina from ischaemia/reperfusion by stimulating alpha(2)-adrenoceptors and not by an action on imidazoline receptors.
Chao HM; Osborne NN
Brain Res; 2001 Jun; 904(1):126-36. PubMed ID: 11516418
[TBL] [Abstract][Full Text] [Related]
14. Ocular distribution after topical instillation and potential neuroprotective effect after intravitreal injection of the calcium channel blocker iganipidine.
Ohashi M; Saito S; Fukaya Y; Tomidokoro A; Araie M; Kashwagi K; Suzuki Y
Curr Eye Res; 2005 Apr; 30(4):309-17. PubMed ID: 16020261
[TBL] [Abstract][Full Text] [Related]
15. Neuroprotective effects of eliprodil in retinal excitotoxicity and ischemia.
Kapin MA; Doshi R; Scatton B; DeSantis LM; Chandler ML
Invest Ophthalmol Vis Sci; 1999 May; 40(6):1177-82. PubMed ID: 10235551
[TBL] [Abstract][Full Text] [Related]
16. Effects of betaxolol on light responses and membrane conductance in retinal ganglion cells.
Gross RL; Hensley SH; Gao F; Yang XL; Dai SC; Wu SM
Invest Ophthalmol Vis Sci; 2000 Mar; 41(3):722-8. PubMed ID: 10711687
[TBL] [Abstract][Full Text] [Related]
17. Inner retinal neurons display differential responses to N-methyl-D-aspartate receptor activation.
Sun D; Rait JL; Kalloniatis M
J Comp Neurol; 2003 Oct; 465(1):38-56. PubMed ID: 12926015
[TBL] [Abstract][Full Text] [Related]
18. Expression and neuroprotective effect of hepatocyte growth factor in retinal ischemia-reperfusion injury.
Shibuki H; Katai N; Kuroiwa S; Kurokawa T; Arai J; Matsumoto K; Nakamura T; Yoshimura N
Invest Ophthalmol Vis Sci; 2002 Feb; 43(2):528-36. PubMed ID: 11818401
[TBL] [Abstract][Full Text] [Related]
19. Levobetaxolol-induced Up-regulation of retinal bFGF and CNTF mRNAs and preservation of retinal function against a photic-induced retinopathy.
Agarwal N; Martin E; Krishnamoorthy RR; Landers R; Wen R; Krueger S; Kapin MA; Collier RJ
Exp Eye Res; 2002 Apr; 74(4):445-53. PubMed ID: 12076088
[TBL] [Abstract][Full Text] [Related]
20. Sulfisoxazole, an endothelin receptor antagonist, protects retinal neurones from insults of ischemia/reperfusion or lipopolysaccharide.
Syed H; Safa R; Chidlow G; Osborne NN
Neurochem Int; 2006 Jun; 48(8):708-17. PubMed ID: 16464516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
